Surfactant in the middle ear and eustachian tube: A review

International Journal of Pediatric Otorhinolaryngology

Volumn 66, Issue 1, 2002, Pages 1-15

  McGuire, John F ^a  

^a GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Eustachian tube; Free radical; Mucociliary clearance; Mucus rheology; Otitis media; Surfactant proteins

Indexed keywords

CALCIUM; DNA; M PROTEIN; MUCIN; PHOSPHOLIPID; SURFACTANT; WATER;

AUDITORY TUBE; CILIATED EPITHELIUM; FLOW KINETICS; HUMAN; IMMUNE SYSTEM; IMMUNOLOGY; MIDDLE EAR; MUCUS; OTITIS MEDIA; PHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SURFACE TENSION; TYMPANOSTOMY TUBE;

EUSTACHIAN TUBE; FREE RADICALS; HUMANS; IMMUNITY, NATURAL; MUCOCILIARY CLEARANCE; MUCUS; PULMONARY SURFACTANT-ASSOCIATED PROTEINS; PULMONARY SURFACTANTS; SURFACE TENSION;

EID: 0037152590     PISSN: 01655876     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5876(02)00203-3     Document Type: Review

References (76)

1. Daniels C., Orgeig S. The comparative biology of pulmonary surfactant: past, present, future. Comp. Biochem. Physiol. Part A. 129:2001;9-36.
2. Bourbon J., Chailley-Heu B. Surfactant proteins in the digestive tract, mesentery, and other organs: evolutionary significance. Comp. Biochem. Physiol. Part A. 129:2001;151-161.
3. Khubchandani K., Snyder J. Surfactant protein A (SP-A): the alveolus and beyond. FASEB. 15:2001;59-69.
4. Banerjee R., Puniyani R. Exogenous surfactant therapy and mucus rheology in chronic obstructive airway diseases. J. Biomat. Appl. 14:2000;243-272.
5. Wheeler S.L., Pool G.L., Lumb R.H. Rat eustachian tube synthesizes disaturated phosphatidylcholine. Biochem. Biophys. Acta. 794:1984;348-349. Abstract.
6. Coticchia J., Heiselman F., Gharbo R., Demaria T.F., Lim D.J. Surface active substances in the Chinchilla tubotympanum; a biochemical study. Acta Otolaryngol. (Stockholm). 111:1991;1097-1104.
7. Paananen R., Postle A., Clark G., Glumoff V., Hallman M. Eustachian tube surfactant is different from alveolar surfactant. Determination of phospholipid content of porcirine Eustachian tube lavage fluid. J. Lipid Res. 43:(1):2002;99-106.
8. Svane-Knudsen V., Larsen H., Brask T. Secretory otitis media - a question of surface activity in the Eustachian tube. Acta Otolaryngol. (Stockholm). 105:1988;114-119.
9. Paananen R., Sormunen R., Glumoff V., Eijk M.V., Hallman M. Surfactant proteins A and D in Eustachian tube epithelium. Am. J. Physiol. Lung Cell. Mol. Physiol. 281:2001;L660-L667.
10. Phelps D. Surfactant regulation of host defense function in the lung: a question of balance. Pediatr. Pathol. Mol. Med. 20:2001;269-292.
11. LeVine A., Kurak K., Wright J.R., Watford W., Vruno M.D., Ross G.F., et al. Surfactant protein-a binds Group B streptococcus enhancing phagocytosis and clearance from lungs of surfactant protein-A-deficient mice. Am. J. Respir. Cell. Mol. Biol. 20:1999;279-286.
12. LeVine A., Whitsett J., Gwozdz J., Richardson T.R., Fisher J.H., Burhans M.S., et al. Distinct effects of surfactant protein A or D deficiency during bacterial infection on the lung. J. Immunol. 165:2000;3934-3940.
13. Ikegami M., Weaver T.E., Conkright J.J., Sly P.D., Ross G.F., Whitsett J.A., et al. Deficiency of SP-B reveals protective role of SP-C during oxygen lung injury. J. Appl. Physiol. 92:2002;519-526.
14. Borron P., McIntosh C., Korfhagen T.R., Whitsett J.A., Taylor J., Wright J.R. Surfactant-associated protein A inhibits LPS-induced cytokine and nitric oxide production in vivo. Am. J. Physiol. Lung Cell. Mol. Physiol. 278:2000;L840-L847.
15. Ramet M., Lofgren J., Alho O., Hallman M. Surfactant protein-A gene locus associated with recurrent otitis media. J. Pediatr. 138:(2):2001;266-268.
16. Clark J.C., Wert S.E., Bachurski C.J., Stahlman M.T., Stripp B.R., Weaver T.E. Targeted disruption of the surfactant protein B gene disrupts surfactant homeostasis causing respiratory failure in newborn mice. PNAS. 92:1995;7794-7798.
17. Paananen R., Glumoff V., Sormunen R., Voorhout W., Hallman M. Expression and localization of lung surfactant protein B in Eustachian tube epithelium. Am. J. Physiol. Lung Cell. Mol. Physiol. 280:2001;L214-220.
18. Ingenito E., Mora R., Cullivan M., Marzan Y., Haley K., Mark L., et al. Decreased surfactant protein B expression and surfactant dysfuntion in a murine model of acute lung injury. Am. J. Respir. Cell. Mol. Biol. 25:2001;35-44.
19. Lim D.J., Chun Y.M., Lee H.Y., Moon S.K., Chang K.H., Li J., et al. Cell biology of tubotympanum in relation to pathogenesis of otitis media - a review. Vaccine. 19:(Suppl. 1):2000;S17-25.
20. Dutton J.M., Goss K., Khubchandani K.R., Shah C.D., Smith R., Snyder J.M. Surfactant protein A in rabbit sinus and middle ear mucosa. Ann. Otol. Rhinol. Laryngol. 108:(10):1999;915-924.
21. Taneva S., Keough K. Adsorption of pulmonary surfactant protein SP-A to monolayers of phospholipids containing hydrophobic surfactant protein SP-B or SP-C: potential differential role for tertiary interations of lipids, hydrophobic proteins, and SP-A. Biochemistry. 39:2000;6083-6093.
22. Glasser S.W., Burhans M.S., Korfhagen T.R., Na C., Sly P.D., Ross G.F., et al. Altered stability of pulmonary surfactant in SP-C-deficient mice. PNAS. 98:(11):2001;6366-6371.
23. R. Paananen, Characterization of surfactant proteins in the porcine Eustachian tube, Acta Univ. Ouluensis Med. (2001).
24. Paananen R., Glumoff V., Hallman M. Surfactant protein A and D expression in the porcine Eustachian tube. FEBS Lett. 452:(3):1999;141-144.
25. Korfhagen T.R., Sheftelyevich V., Burhans M.S., Bruno M.D., Ross G.F., Wert S.E., et al. Surfactant protein D regulates surfactant phospholipid homeostasis in vivo. J. Biol. Chem. 273:1998;28438-28443.
26. Fisher J.H., Shetelyevich V., Ho Y.S., Fligiel S., McCormack F.X., Korfhagen T.R. Pulmonary-specific expression of SP-D corrects pulmonary lipid accumulation in SP-D gene-targeted mice. Am. J. Physiol. Lung Cell. Mol. Physiol. 27:(2):2000;L365-L373. Abstract.
27. Madsen J., Kleim A., Tornoe I., Skjodt K., Koch C., Holmskov U. Localization of surfactant protein D on mucosal surfaces in human tissues. J. Immunol. 164:2000;5866-5870.
28. Lu J. Collectins: collectors of microorganisms for the innate immune system. Bioessays. 19:(6):1997;509-518.
29. Holmskov U., Malhotra R., Sim R.B., Jensenius J.C. Collectins: collagenous C-type lectins of the innate immune defense system. Immunol. Today. 15:(2):1994;67-74.
30. Suwabe A., Otake K., Yakuwa N., Suzuki H., Ito M., Tomoike H., et al. Artificial surfactant (surfactant TA) modulates adherence and superoxide production of neutrophils. Am. J. Respir. Crit. Care Med. 158:1998;1890-1899.
31. Schagat T., Wofford J., Wright J.R. Surfactant protein A enhances alveolar macrophage phagocytosis of apoptotic neutrophils. J. Immunol. 166:2001;2727-2733.
32. Watford W.T., Wright J.R., Hester C.G., Jiang H., Frank M.M. Surfactant protein A regulates compliment activation. J. Immunol. 167:2001;6593-6600.
33. LeVine A., Whitsett J., Hartshorn K.L., Crouch E., Korfhagen T.R. Surfactant protein D enhances clearance of influenza A virus from the lung in vivo. J. Immunol. 167:2001;5868-5873.
34. LeVine A.M., Bruno M.D., Huelsman K.M., Ross G.F., Whitsett J.A., Korfhagen T.R. Surfactant protein A-deficient mice are suseptable to Group B Streptococcal infection. J. Immunol. 158:1997;4336-4340.
35. Flisberg K., Ingested P.S., Ortegren U. The valve and 'locking' mechanism of the Eustachian tube. Acta Otolaryngol. 182:1963;57-68.
36. Bluestone C., Klein J. Otitis media, atelectasis, and Eustachian tube dysfunction. Bluestone C.D., Stool S.E., Kenna M.A., Pediatric Otolaryngology. third ed. 1996;388-582 Saunders, Philadelphia, PN.
37. Malm L., White P. Beta-Agonists and surfactant in Eustachian tube function. Acta Otolaryngol. (Stockholm). 493:(Suppl.):1992;133-136.
38. Fornadley J.A., Burns J.K. The effect of surfactant on Eustachian tube function in a gerbil model of otitis media with effusion. Otolaryngol. Head Neck Surg. 110:(1):1994;110-114.
39. Nemechek A.J., Pahlavan N., Cote D.N. Nebulized surfactant for experimentally induced otitis media with effusion. Otolarygol. Head Neck Surg. 117:(5):1997;475-479.
40. Koten M., Uzun C., Yagiz R., Kemal A., Karasalihoglu A.R., Tatman-Otkun M., et al. Nebulized surfactant as a treatment choice for otitis media with effusion: an experimental study in the rabbit. J. Laryngol. Otol. 115:2001;363-368.
41. Venkatayan N., Troublefield Y., Connelly P.E., Mautone A.J., Chandresekhar S.S. Intranasal surfactant aerosol therapy for otitis media with effusion. Laryngoscope. 110:2000;1857-1860.
42. Chandrasekhar S.S., Connelly P.E., Venkatayan N., Ammar M., Tabor M., Mautone A. Intranasal metered dose aerosolized surfactant reduces passive opening pressure of the Eustachian tube: comparison study in two animal models. Otol. Neurotol. 23:2002;3-7.
43. Passali D., Zavattini G. Multicenter study on the treatment of secretory otitis media with Ambroxol. Respiration. 51:(Suppl. 1):1987;52-59.
44. White P., Hermansson A., Svinhufvud M. Surfactant and isoprenaline effect on Eustachian tube opening in rats with acute otitis media. Am. J. Otolaryngol. 11:1990;389-392.
45. King M. Experimental models for studying mucociliary clearance. Eur. Respir. J. 11:1998;222-228.
46. Majima Y., Harada T., Shimizu T., Takeuchi K., Sakakura Y., Tasuoka S., et al. Effect of biochemical components on rheologic properties of nasal mucus in chronic sinusitis. Am. J. Respir. Crit. Care Med. 160:1999;421-426.
47. Puchelle E., Bentzmann S., Zahm J.M. Physical and functional properties of airway secretions in cystic fibrosis - theraputic approaches. Respiration. 62:(Suppl. 1):1995;2-12.
48. Lin J., Tsuprun V., Kawano H., Paparella M.M., Zhang Z., Anway R., Ho S.B. Characterization of mucins in human middle ear and Eustachian tube. Am. J. Physiol. Lung Cell. Mol. Physiol. 280:2001;L1157-L1167.
49. Kawano H., Paparella M.M., Ho S.B., Schachern P.A., Morizono N., Le C.T. Identification of MUC5B mucin gene in human middle ear with chronic otitis media. Laryngoscope. 110:2000;668-673.
50. Hutton D.A., Fogg F.J., Kubba H., Birchall J.P., Pearson J.P. Heterogenicity in the protein cores of mucins isolated from human middle ear effusions: evidence for expression of different mucin gene products. Glycoconjugate J. 15:1998;283-291.
51. King M., Dasgupta B., Tomkiewicz R.P., Brown N.E. Rheology of cystic fibrosis sputum after in vitro treatment with hypertonic saline alone and in combination with recombinant human deoxyribonuclease I. Am. J. Respir. Crit. Care Med. 156:(1):1997;173-177.
52. Bos M., Vliet T. Interfacial rheological properties of adsorbed protein layers and surfactants: a review. Adv. Colloid Interf. Sci. 91:2001;437-471.
53. Ridsdale R.A., Palaniyar N., Possmayer F., Horanz G. Formation of folds and vesicles by dipalmitoylphosphatidylcholine monolayers spread in excess. J. Membr. Biol. 180:2001;21-32.
54. King D.M., Wang Z., Palmer H.J., Holm B.A., Notter R.H. Bulk shear viscosities of endogenous and exogenous lung surfactants. Am. J. Physiol. Lung Cell. Mol. Physiol. 282:2002;L277-L284.
55. Palaniyar N., Ikegami M., Korfhagen T., Whitsett J., McCormack F.X. Domains of surfactant protein A that affect protein oligomerization, lipid structure and surface tension. Comp. Biochem. Physiol. Part A. 129:2001;109-127.
56. De Sanctis G.T., Tomkiewicz R.P., Rubin B.K., Schurch S., King M. Exogenous surfactant enhances mucociliary clearance in the anaesthetized dog. Eur. Respir. J. 7:(9):1994;1616-1621.
57. Kakuta Y., Sasaki H., Takishima T. Effect of artificial surfactant on ciliary beat frequency in guinea pig trachea. Respir. Physiol. 83:(3):1991;313-321.
58. Outzen K., Svane-Knudsen V. Effect of surface-active substance on nasal mucociliary clearance time: a comparison of saccharin clearance time before and after the use of surface-active substance. Rhinology. 31:1993;155-157.
59. Anzueto A., Jubran A., Ohar J.A., Piquette C.A., Rennard S.I., Colice G. Effects of aerosolized surfactant in patients with stable chronic bronchitis: a prospective randomized controlled trial. J. Am. Med. Assoc. 278:1997;1426-1431.
60. Takahashi H., Honjo I., Hayashi M., Fujita A. Clearance function of Eustachian tube and negative middle ear pressure. Ann. Otol. Rhinol. Laryngol. 102:1992;759-762.
61. Rubin B., Ramirez O., King M. Mucus rheology and transport in neonatal respiratory distress syndrome and the effect of surfactant therapy. Chest. 101:(4):1992;1080-1085.
62. Armengot M., Escribano A., Carda C., Basterra J. Clinical and ultrastructural correlations in nasal mucociliary function observed in children with recurrent airway infections. Int. J. Pediatr. Otolaryngol. 32:1995;143-151.
63. Mattson C., Marklund S., Hellstrom S. Application of oxygen free radical scavengers to diminish the occurrence of myringosclerosis. Ann. Otol. Rhinol. Laryngol. 106:1997;513-518.
64. Bridges J.P., Davis H.W., Damodarasamy M., Kuroki Y., Howles G., Hui D.Y., et al. Pulmonary surfactant proteins A and D are potent endogenous inhibitors of lipid peroxidation and oxidative cellular injury. J. Biol. Chem. 275:(9):2000;38848-38855.
65. Minoo P., King R.J., Coalson J.J. Surfactant proteins and lipids are regulated independently during hyperoxia. Am. J. Physiol. Lung Cell. Mol. Physiol. 263:1992;L291-L298.
66. Parks R.R., Huang C.C., Haddad J. Evidence of oxygen free radical injury in experimental otitis media. Laryngoscope. 104:1994;1389-1392.
67. Takoudes T., Haddad J. Hydrogen peroxide in acute otitis media in guinea pigs. Laryngoscope. 107:1997;206-210.
68. Schousboe L., Ovesen T., Ledet T. Influence of hyperoxia on in vitro growth of rabbit middle ear epithelium and auditory meatal epithelium. Int. J. Pediatr. Otorhinolarygol. 41:1997;279-290.
69. Felding J. Middle ear gas - its composition in the normal and in the tubulated ear: a methodological and clinical study. Acta Otolaryngol. (Stockholm). 536:(Suppl.):1998;1-57.
70. Spratley J., Hellstrom S., Mattson C.K., Pais-Clemente M. Topical ascorbic acid reduces myringosclerosis in perforated tympanic membranes. Ann. Otol. Rhinol. Laryngol. 110:2001;585-591.
71. Harrod K., Trapell B., Trapnell B.C., Otake K., Korfhagen T.R., Whitsett J.A. SP-A enhances viral clearance and inhibits inflammation after pulmonary adenoviral infection. Am. J. Physiol. 277:(3 Pt. 1):1999;L580-L588. Abstract.
72. Linke M.J., Harris C.E., Korfhagen T.R., McCormack X.R., Ashbaugh A.D., Steele P. Immunosuppressed surfactant protein A-deficient mice have increased suseptability to Pneumocystis carinii infection. J. Infect. Dis. 183:(6):2000;943-952. Abstract.
73. Wert S., Yoshida M., LeVine A.M., Ikegami M., Jones T., Ross G., et al. Increased metalloproteinase activity, oxidant production, and emphysema in surfactant protein D gene-inactivated mice. PNAS. 97:(11):2000;5972-5977.
74. Stahlman M.T., Gray M.P., Falconieri M., Whitsett J.A., Weaver T.E. Lamellar body formation in normal and surfactant protein B-deficient fetal mice. Lab. Invest. 80:(3):2000;395-403. Abstract.
75. Tokieda K., Ikegami M., Wert S.E., Baatz J.E., Zon Y., Whitsett J.A. Surfactant protein B corrects oxygen-induced pulmonary dysfunction in heterozygous surfactant protein B-deficient mice. Pediatr. Res. 46:(6):1999;708-714. Abstract.
76. Tong H.H., Chen Y., James M., Van Deusen J., Welling D.B., DeMaria T.F. Expression of cytokine and chemokine genes by human middle ear epithelial cells induced by formalin-killed Haemophilus influenzae or its lipooligosaccaride htrB and rfaD mutants. Infect. Immun. 69:(6):2001;3678-3684.